EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor Organoid and Spheroid Models for Cervical Cancer

Ivana Kutle, Robert Polten, Jens Hachenberg iD, Rüdiger Klapdor iD, Michael Morgan, Axel Schambach

Cancers · 27.04.2023 · 15 (9) · 2518

DOI: 10.3390/cancers15092518 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.04.2023. Verfasst von Ivana Kutle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comprehensive Cancer Center Niedersachsen, Bruno und Helene Jöster Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is one of the most common malignant diseases in women worldwide. Despite the global introduction of a preventive vaccine against the leading cause of cervical cancer, human papillomavirus (HPV) infection, the incidence of this malignant disease is still very high, especially in economically challenged areas. New advances in cancer therapy, especially the rapid development and application of different immunotherapy strategies, have shown promising pre-clinical and clinical results. However, mortality from advanced stages of cervical cancer remains a significant concern. Precise and thorough evaluation of potential novel anti-cancer therapies in pre-clinical phases is indispensable for efficient development of new, more successful treatment options for cancer patients. Recently, 3D tumor models have become the gold standard in pre-clinical cancer research due to their capacity to better mimic the architecture and microenvironment of tumor tissue as compared to standard two-dimensional (2D) cell cultures. This review will focus on the application of spheroids and patient-derived organoids (PDOs) as tumor models to develop novel therapies against cervical cancer, with an emphasis on the immunotherapies that specifically target cancer cells and modulate the tumor microenvironment (TME).

Schlagwörter

Stichwörter der Autor:innen

3D tumor modelscervical cancerimmunotherapypatient-derived organoids (PDOs)pre-clinical drug teststumor microenvironment (TME)tumor spheroids

Autor:innen und Institutionen

  • Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany.
  • Department of Obstetrics and Gynecology, Hannover Medical School, 30625 Hannover, Germany.
  • Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Jens Hachenberg, Rüdiger Klapdor

Förderung

  • Comprehensive Cancer Center Niedersachsen
  • Bruno und Helene Jöster Foundation
  • Deutsche Forschungsgemeinschaft
  • Federal Ministry of Education and Research
  • REBIRTH Center for Translational Regenerative Medicine
  • Bruno and Helene Jöster Foundation
  • German Research Foundation (DFG)
  • REBIRTH Center for Translational Regenerative Medicine through the State of Lower Saxony

Zitieren

APA

Kutle, I., Polten, R., Hachenberg, J., Klapdor, R., Morgan, M., & Schambach, A. (2023). Tumor Organoid and Spheroid Models for Cervical Cancer. Cancers, 15(9), 2518. https://doi.org/10.3390/cancers15092518

Vancouver

Kutle I, Polten R, Hachenberg J, Klapdor R, Morgan M, Schambach A. Tumor Organoid and Spheroid Models for Cervical Cancer. Cancers. 2023;15(9):2518. doi:10.3390/cancers15092518

BibTeX
@article{Kutle2023,
  author = {Kutle, Ivana and Polten, Robert and Hachenberg, Jens and Klapdor, Rüdiger and Morgan, Michael and Schambach, Axel},
  title = {Tumor Organoid and Spheroid Models for Cervical Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {9},
  pages = {2518},
  doi = {10.3390/cancers15092518}
}
Kostenlos starten →